Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
but has yet to receive subsequent doses; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 18-year-old male patient who did not receive Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (1st dose received intramuscularly on 19-AUG-2024). The patient did not receive the 2nd dose of Bexsero. The patient had incomplete course of vaccination (Verbatim: but has yet to receive subsequent doses). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-AUG-2025 The reporter was the mother of the patient. The reporter's son (patient) received dose one of Bexsero but had yet to receive subsequent doses. Till the time of reporting, the patient did not receive 2nd dose of Bexsero, which led to an incomplete course of vaccination.